NCT02621060View on ClinicalTrials.gov

Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

February 29, 2016

Conditions
Impaired Glucose Tolerance
Interventions
DRUG

Placebo

Placebo: 1200 mg per day for three months

DRUG

Chlorogenic acid

Chologenic acid: 1200 mg per day for three months

Trial Locations (1)

44340

Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT02621060 - Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance | Biotech Hunter | Biotech Hunter